In resting platelets, adhesive membrane glycoproteins are attached to the cytoskeleton. On strong activation, phosphatidylserine(PS)-positive and -negative platelet subpopulations are formed. Platelet activation is accompanied by cytoskeletal rearrangement, although the glycoprotein attachment status in these two subpopulations is not clear. We developed a new, flow cytometry-based, single-cell approach to investigate attachment of membrane glycoproteins to the cytoskeleton in cell subpopulations. In PS-negative platelets, adhesive glycoproteins integrin α IIb β 3 , glycoprotein Ib and, as shown for the first time, P-selectin were associated with the cytoskeleton. In contrast, this attachment was disrupted in PS-positive platelets; it was retained to some extent only in the small convex regions or 'caps'. It correlated with the degradation of talin and filamin observed only in PS-positive platelets. Calpain inhibitors essentially prevented the disruption of membrane glycoprotein attachment in PSpositive platelets, as well as talin and filamin degradation. With the suggestion that detachment of glycoproteins from the cytoskeleton may affect platelet adhesive properties, we investigated the ability of PS-positive platelets to resist shearinduced breakaway from the immobilized fibrinogen. Shear rates of 500/s caused PS-positive platelet breakaway, but their adhesion stability increased more than 10-fold after pretreatment of the platelets with calpain inhibitor. In contrast, the ability of PSpositive platelets to adhere to immobilized von Willebrand's factor at 100/s was low, but this was not affected by the preincubation of platelets with a calpain inhibitor. Our data suggest that calpain-controlled detachment of membrane glycoproteins is a new mechanism that is responsible for the loss of ability of the procoagulant platelets to resist detachment from thrombi by high shear stress.
INTRODUCTION
Platelets contain a cytoplasmic skeleton composed of a network of actin filaments [1] , and a membrane skeleton composed of short actin filaments cross-linked by actin-binding proteins [2] . Previous studies suggested that cytoplasmic domains of the adhesive membrane glycoproteins are associated with the platelet membrane skeleton [3, 4] , thus allowing a cell to adhere as a whole; this is a widespread mechanism for cell adhesion molecules, the most important of which are heterodimeric transmembrane aggregatory receptors of the integrin family [5] and the adhesive receptor glycoprotein Ib (GpIb)-V-IX [6] . Another major receptor, P-selectin, mediates adhesive interactions of platelets with leukocytes and endothelial cells [7] , but to the best of our knowledge this P-selectin association with the cytoskeleton has not been reported.
The most studied association is that of the main mediator of the aggregation integrin α IIb β 3 and the main adhesion molecule GpIb with the cytoskeleton. On platelet activation, integrin α IIb β 3 develops the ability to bind its main adhesive ligand, fibrinogen.
In response to extracellular ligand binding, integrins undergo a conformational switch that permits recruitment of cytoplasmic adapter proteins, eventually linking the integrin receptors to the actin cytoskeleton, progressively forming highly complex cellmatrix adhesions [5] . Integrins associate with intracellular actin filaments through a variety of cytoskeletal proteins [8] , and the best understood linkage is through talin. Talin's head domain binds some sequences in the β-integrin cytoplasmic domains, whereas its tail domain binds actin, both directly and indirectly via vinculin [9] .
There is another mechanism of association with the cytoskeleton for GpIb-V-IX, which represents a multifunctional receptor able to interact with a number of ligands, including the adhesive protein von Willebrand's factor (vWf) and the main coagulation factor thrombin. The cytoplasmic tail of GpIbα contains binding sites for platelet cytoskeletal proteins, such as the actin-binding protein [10, 11] and other adaptor proteins [12] . These interactions are important for the regulation of vWfinduced platelet adhesion and activation. Only a small percentage of the membrane surface proteins and glycoproteins were found in the cytoskeletal structures from either washed platelets or thrombin-activated platelets [13] . In contrast, the cytoskeletal structures from thrombin-aggregated platelets contained integrin α IIb β 3 and GpIb [3] . These results suggest that glycoproteins participate in the direct interaction of platelets during aggregation [13] .
Another important adhesion molecule of stimulated platelets is the glycoprotein P-selectin, which mediates the interaction of platelets with neutrophils and monocytes [14, 15] . P-selectin is a membrane component of cell storage granules and a member of the selectin family. Its association with the membrane skeleton has not yet been investigated and discussed, but it has long been hypothesized that all adhesions function as a 'molecular clutch' between the actin cytoskeleton and extracellular ligands, using actin dynamics to mediate the transmission of forces to the extracellular environment [16] .
Furthermore, it is not clear how the interaction of these three receptor types with the cytoskeleton changes on platelet activation. This is additionally complicated by the fact that resting platelets can be transformed into two activated forms (platelet subpopulations) with dramatically different properties: either a well-aggregating form with filopodia and lamellipodia that derive from a remodelled actin skeleton and a massive assembly of new actin filaments [17] , or a balloon-shaped state with high levels of cytoplasmic Ca 2 + and procoagulant response [18] but insufficient aggregation capability [19] .
Early studies suggested that cytoskeletal protein degradation is controlled by the calcium-activated protease calpain [20] . Platelets have two forms of calpain distinguished by the intracellular Ca 2 + concentration required for their activation. The first form (μ-calpain) is active in the Ca 2 + concentration range 5-50 μM, whereas the second one (m-calpain) is active in the Ca 2 + concentration range 200-1000 μM [21] . Subpopulations of activated platelets are known to have different intracellular Ca 2 + concentrations [22] which may possibly lead to the activation of different forms of calpain.
In the present study, we have developed a new approach based on flow cytometry for the detection of membrane glycoprotein attachment to the membrane skeleton. Our method is based on the fixation of stained platelets and their subsequent detergent treatment, causing the release of degraded membrane proteins from the platelet cytoskeleton. A similar approach was used for the analysis of platelet cytoskeletal ultrastructure using electron microscopy [23] . Our method is based on the assumption that membrane proteins not attached to the cytoskeleton are removed by postfixation detergent treatment; this effect has previously been observed for some integral membrane proteins [24] .
In the present study, we investigated the attachment of adhesive membrane glycoproteins (integrin α IIb β 3 , GpIb and P-selectin) to the membrane skeleton in platelet subpopulations, and the relationship between the attachment/detachment of adhesive glycoproteins and the adhesive properties of platelets.
EXPERIMENTAL

Materials
The following materials were obtained from the sources shown in brackets: thrombin, human von Willebrand's factor (Haematologic Technologies); prostaglandin E 1 (MP Biochemicals); Alexa Fluor 647-conjugated annexin V, phycoerythrin (PE)-conjugated CD61, CD61-Alexa Fluor 647, CD42b-PE and CD62P-PE (Biolegend); FITC-conjugated PAC-1 antibody (BD Biosciences); calpeptin, MDL28170, PD150606 (Tocris Bioscience); PPACK (EMD Chemicals); and S2238 (Chromogenix). DMSO and all other reagents were of analytical grade (Sigma-Aldrich). Collagen-related peptide (CRP) was kindly provided by Professor R.W. Farndale (University of Cambridge, UK). The active site titration of thrombin was performed using PPACK and S2238, essentially as described [25] .
Platelet isolation
Blood was collected into 3.8 % sodium citrate and supplemented with apyrase (0.1 unit/ml) and prostaglandin E 1 (1 μM). Investigations were performed in accordance with the Declaration of Helsinki, and written informed consent was obtained from all donors. Platelets were purified by centrifugation and gel filtration as described [26, 27] and re-suspended in buffer A (150 mM NaCl, 2.7 mM KCl, 1 mM MgCl 2 , 0.4 mM NaH 2 PO 4 , 20 mM Hepes, 5 mM glucose, 0.5 % BSA, pH 7.4).
Platelet activation
Platelets were diluted in buffer A to a final concentration of 100×10 6 /ml. Then platelets at 50×10 6 /ml were activated by thrombin, thrombin + CRP or calcium ionophore A23187 at room temperature in the presence of 2.5 mM calcium chloride. All experiments were performed without stirring.
Platelet staining with antibodies
The platelets were stained with the antibodies to the activated form of integrin α IIb β 3 (PAC-1-FITC) and to the surface glycoproteins integrin α IIb β 3 (its inactivated form), GpIb and P-selectin (CD61-PE, CD42b-PE or CD62P-PE, respectively) at room temperature. Double staining with PS marker (Alexa Fluor 647-annexin V) and antibodies against the active form of integrin α IIb β 3 (PAC-1-FITC) were used to evaluate the formation of activated platelet subpopulations.
Platelet fixation and detergent treatment
Stained platelets were fixed with freshly prepared 1 % paraformaldehyde for 45 min and then treated with 0.1 % Triton X-100 for 10 min at room temperature. After this platelets were diluted with PBS, pH 7.4, and immediately analysed in a flow cytometer.
Protein electrophoresis
Protein electrophoresis was performed using one-dimensional SDS/PAGE as described by Laemmli [28] . Proteins were visualized with Coomassie Blue or silver stain. For electrophoresis experiments, platelets were purified by gel filtration in buffer A without BSA, and platelet activation was also studied in buffer A without BSA.
Flow cytometry
Platelets were analysed using a FACSCalibur (BD Biosciences) or Accuri C6 (Accuri Cytometers, BD Biosciences) flow cytometer. The acquired data were processed using WinMDI 2.8 (Joseph Trotter, Scripps Research Institute) or CFlow (Accuri Cytometers) software, respectively. Compensation was performed for all types of two-and three-colour analysis. Two subpopulations of activated platelets were gated on dot-plots by their PAC-1-binding properties (PS-positive and PS-negative).
Cell sorting
Activated platelets were stained with annexin V-FITC for 5 min at room temperature and analysed in a cell sorter system BD FACSAria II (BD Biosciences), where they were separated into PS-positive and PS-negative subpopulations.
Analysis of the detachment of membrane glycoproteins from the platelet cytoskeleton in activated platelets using confocal microscopy Glass coverslips (24×24 mm, Heinz Herenz) were cleaned with potassium dichromate, rinsed with distilled water and dried. Then they were coated with 10 mg/ml of fibrinogen in buffer A for 40 min at room temperature, rinsed with distilled water and assembled as part of the flow chamber. Coated coverslips were blocked with 0.5-2 % (w/v) BSA for 30-60 min at room temperature. Gel-filtered platelets at 200×10 6 /ml were incubated with fibrinogen-coated coverslips for 10 min at room temperature. Then the flow chamber was washed at 100/s with buffer A to remove non-adherent platelets. After this, adhered cells were activated with 100 nM thrombin + 10 μg/ml of CRP for 20 min, and double stained with annexin V-Alexa Fluor 647 and CD61-FITC or CD42b-FITC for 10 min to detect PS-positive platelets and membrane glycoproteins. Then the platelets were fixed with paraformaldehyde, treated with detergent and visualized using an Axio Observer.Z1 confocal microscope (Carl Zeiss) with a 100× objective. Data were recorded for offline analysis using ImageJ software.
Platelet resistance to flow-dependent breakaway
Glass coverslips were coated with 10 mg/ml of fibrinogen and assembled as part of the flow chamber. Gel-filtered platelets at 200×10 6 /ml were stained with CD61-Alexa Fluor 647 for 5 min and incubated with fibrinogen-coated coverslips in the absence of shear for 20 min at room temperature. Then the unattached platelets were removed by washing the flow chamber with buffer A at low flow rates (<100/s), and adhered cells were incubated with glass coverslips for another 20 min for complete spreading. The platelets were then incubated with 0.2 % DMSO (control) or 200 μM MDL28 170 in buffer A for 15 min at room temperature. After this, platelets were activated with 10 μM A23 187 in the presence of 2.5 mM calcium chloride for 10 min, and stained with annexin V-FITC for 3 min to visualize PS-positive platelets. Then the platelets were subjected to increasing flow at sequential shear rates of 300, 500, 1000, 1500 and 2000/s for 2 min and 4000, 6000 and 9000/s for 1 min. Platelets were visualized using the Axio Observer.Z1 confocal microscope with a 100× objective. Data were recorded for offline analysis using ImageJ software.
Flow-based adhesion assay
The cleaned coverslips were coated with 100 μg/ml of human vWf for 2 h at room temperature or overnight at + 4
• C, rinsed with distilled water, blocked with 0.5 % (w/v) BSA for 1 h at room temperature and assembled as part of the flow chamber. Gelfiltered platelets at 300×10 6 /ml were preincubated with 0.2 % DMSO (control) or 200 μM MDL28170 for 60 min at room temperature, stained with CD61-Alexa Fluor 647 for 20 min, activated by 10 μM A23 187 in the presence of 2.5 mM calcium chloride for 20 min, and perfused through the flow chamber at a shear rate of 100/s for 10 min. Then the flow chamber was perfused with buffer A at 100/s for another 3 min, and adhered platelets (30 fields of view) were visualized using the Axio Observer.Z1 confocal microscope with a 100× objective. Data were recorded for offline analysis using ImageJ software.
Statistics
Comparisons between two paired sets of values were carried out using the paired Student's t-test. Statistical significance was set at P < 0.05. Experiments were reproduced at least three times with platelets from different donors, and the values are reported as means+ − S.D.
RESULTS
Attachment of membrane glycoproteins to the cytoskeleton in platelet subpopulations
In order to investigate the attachment of membrane glycoproteins to the cytoskeleton in platelet subpopulations, we designed a flow cytometric approach based on the detergent treatment of stained fixed platelets for release of degraded membrane glycoproteins. Activated PS-positive and PS-negative platelets were separated by their different PAC-1 binding: PS-positive platelets are PAC-1 negative, and vice versa [29] .
The attachment of integrin α IIb β 3 to the membrane skeleton was analysed in resting, PS-positive and PS-negative, activated platelets ( Figure 1A ). Resting and activated platelets ( Figure 1A ) were stained with CD61-PE alone or together with PAC-1-FITC, respectively, then fixed, untreated or treated with detergent, and analysed by flow cytometry. We did not observe any difference between resting platelets that were either untreated or treated with detergent ( Figure 1A ), although there was a significant shift in CD61 fluorescence intensity of PAC-1-negative activated platelets after detergent treatment ( Figure 1A ).
For more accurate characterization of the cytometric data, we additionally analysed histograms of fluorescence intensity of activated platelet subpopulations gated by their PAC-1 binding ( Figure 1B ). Histograms of CD61 fluorescence intensity of resting ( Figure 1B ) and PAC-1-positive ( Figure 1B ) platelets before and after detergent treatment were indistinguishable, whereas those of PAC-1-negative (PS-positive) platelets were significantly different ( Figure 1B ). We observed a significant decrease in the fluorescence of activated PAC-1-negative, fixed platelets after detergent treatment compared with untreated platelets ( Figure 1B) .
Thus, the release of the CD61-stained integrin α IIb β 3 from the platelet surface was observed only in PAC1-negative (PS-positive) platelets, but not in PAC1-positive (PS-negative) or resting ones ( Figures 1A and 1B) . These data suggest that the detachment of integrin α IIb β 3 from the membrane skeleton occurs only in PSpositive platelets.
Similar results were obtained for platelets stained with CD42b-PE ( Figure 2 ) and CD62P-PE ( Figure 3A) , fluorophoreconjugated antibodies to GpIb and P-selectin, respectively.
As a result of the suggestion that the attachment of membrane glycoproteins to the cytoskeleton may be controlled by the degradation of key proteins (filamin and talin) involved in the cytoskeletal association of glycoproteins, we used protein electrophoresis to test the hypothesis that degradation of filamin and talin occurs only in activated PS-positive platelets. Using a cell sorter, we isolated activated platelets into two groups based on their different annexin V binding (PS-positive and PSnegative), and then we analysed them by protein electrophoresis ( Figure 3B) . We detected the degradation of cytoskeletal proteins Resting platelets were stained with CD61-PE for 10 min at room temperature, and then the platelets were fixed, treated with detergent and analysed by flow cytometry. Platelets were activated by thrombin (100 nM) and CRP (10 μg/ml) for 20 min at room temperature. Activated platelets were double stained with PAC1-FITC and CD61-PE for 10 min at room temperature, and then the platelets were fixed, treated with detergent and analysed by flow cytometry. The results of a typical experiment are presented (n = 4): (A) dot-plots of fixed resting and activated platelets before and after detergent treatment; and (B) CD61 fluorescence histograms of resting platelets and activated PAC-1-positive (PAC1 + ) and activated PAC-1-negative (PAC1 − ) ones before (black) and after (grey) detergent treatment.
such as filamin, talin and myosin only in activated PS-positive platelets, but not in activated PS-negative ones ( Figure 3B ). Protein identification (talin, filamin and myosin) was performed using MS as previously described [30] . This result indicates that the degradation of cytoskeletal proteins involved in the corresponding attachment of membrane glycoproteins is observed only in activated PS-positive platelets, consistent with our cytometric data, which indicate that detachment of key adhesive glycoproteins from the membrane skeleton is detected only in this subpopulation of activated platelets.
Figure 2 Analysis of GpIb attachment to the cytoskeleton in platelet subpopulations
Resting platelets were stained with CD42b-PE for 10 min at room temperature, and then the platelets were fixed, treated with detergent and analysed by flow cytometry. Platelets were activated by thrombin (100 nM) and CRP (10 μg/ml) for 20 min at room temperature. Activated platelets were double stained with PAC-1-FITC and CD42b-PE for 10 min at room temperature, and then the platelets were fixed, treated with detergent and analysed by flow cytometry. The results of a typical experiment are presented (n = 4): (A) dot-plots of resting and activated platelets before and after detergent treatment; and (B) CD42b fluorescence histograms of resting platelets and activated PAC1 + and PAC1 − platelets before (black) and after (grey) detergent treatment.
To prevent possible artefacts associated with cell sorting, we also estimated, by electrophoresis, the dependence of the observed degradation of some cytoskeletal proteins on the extent of platelet activation detected by flow cytometry (see Supplementary Figures S1A and S1B) . The platelets were activated by various concentrations of CRP/thrombin and analysed by flow cytometry (see Supplementary Figure S1A ) and protein electrophoresis (see Supplementary Figure S1B ). The formation of PS-positive platelets increased with increasing agonist concentration (see Supplementary Figure S1A ), as did the degradation of cytoskeletal proteins identified as talin, filamin and myosin (see Supplementary Figure S1B ). In agreement with previous observations [31] , major degradation products of filamin, talin and myosin were found at 190, 135, 93, 50 and 30 kDa.
In our experiments the separation of activated platelets on PSpositive and PS-negative subpopulations was performed due to their different PAC-1 binding (an antibody against an active form of integrin α IIb β 3 ). The absence of integrin α IIb β 3 activation in activated PS-positive platelets was demonstrated by two-colour flow cytometry using FITC-PAC-1 and Alexa Fluor 647-annexin V. On potent stimulation with CRP/thrombin, a population of platelets binding PAC-1 was initially formed, but it was then gradually replaced by a population of PAC-1-negative platelets that bound annexin V (see Supplementary Figures S1C-S1E ). This result correlated completely with previous studies [32] .
All these results suggest that the degradation of cytoskeletal proteins associated with the anchoring of membrane proteins to the cytoskeleton occurs only in activated PS-positive platelets.
Effect of calpain inhibitors on cytoskeletal protein degradation, PS exposure and integrin α IIb β 3 (in)activation in platelet subpopulations
The cytoskeletal proteins filamin (270 kDa), talin (230 kDa) and myosin heavy chain (200 kDa) are major substrates of calpain in human platelets [33] . We analysed the effect of different calpain inhibitors on the cytoskeletal protein degradation by protein electrophoresis (see Supplementary Figure S2A ). Three calpain inhibitors (calpeptin, MDL28170 and PD150606) with different chemical structures and mechanisms of action [34] were used. Complete degradation of filamin and talin (see Supplementary Figure S2A ) was observed in platelets activated by A23187 (all activated platelets were PS positive, data not shown). This effect was prevented by pretreatment of platelets with the calpain inhibitors calpeptin and MDL28170 (see Supplementary Figure S2A ), whereas calpain inhibition with PD150606 resulted in only a negligible decrease in degradation of filamin and talin (see Supplementary Figure S2A ). Neither of the calpain inhibitors affected PS exposure (see Supplementary Figure S2B ).
To test further whether calpain inhibitors are capable of preventing the detachment of membrane glycoproteins from the cytoskeleton, we analysed the effects of these inhibitors on both the process of integrin α IIb β 3 inactivation in PS-positive platelets and the binding of PAC-1 to PS-negative ones. Neither of the calpain inhibitors significantly affected integrin α IIb β 3 status in response to thrombin (see Supplementary Figures S2C and S2D) . These results allowed us to use the preincubation of platelets with calpain inhibitors before further separation of activated platelets on PAC-1-negative (PS-positive) and PAC-1-positive (PS-negative) cells.
Calpain controls the attachment of membrane glycoproteins to the cytoskeleton in PS-positive platelets
The linkage between membrane glycoproteins and actin is accomplished via a complex set of interactions and it is not clear how calpain activation contributes to the detachment of membrane glycoproteins. To investigate the effect of calpain activation on the attachment of membrane glycoproteins to the membrane skeleton, we used our method based on flow cytometry. We analysed the attachment of integrin α IIb β 3 to the membrane skeleton in platelet subpopulations in the presence of calpain inhibitors. All dot-plots and histograms were analysed as described above. Preincubation of platelets with the calpain inhibitor calpeptin or MDL28170 (but not PD150606) significantly inhibited the detachment of membrane glycoproteins observed in activated PS-positive platelets (Figure 4 ). This implies that detachment of membrane glycoproteins in PS-positive platelets is mainly controlled by the calcium-activated protease calpain.
PS exposure precedes the remodelling of the platelet cytoskeleton
Our results suggest that PS exposure and platelet cytoskeletal remodelling are related processes. However, it is unclear which event precedes which. To analyse the sequence of events that occur on strong platelet stimulation, we studied the kinetics of membrane glycoprotein detachment from the platelet cytoskeleton and the kinetics of PS exposure (integrin α IIb β 3 inactivation) using our flow cytometry method. Integrin α IIb β 3 detachment (decrease in CD61 fluorescence) from the platelet cytoskeleton was observed only in PAC-1-negative (PS-positive) platelets. It was detected after 2 min of platelet stimulation and continued for another 4 min ( Figure 5 ). These observations indicate that the remodelling of the platelet cytoskeleton continues after PS exposure. We suggest that PS exposure precedes the remodelling of the platelet cytoskeleton, although this does not necessarily imply any direct causal relationship.
Analysis of the detachment of membrane glycoproteins from the cytoskeleton in activated platelet subpopulations using confocal microscopy
In addition to our flow cytometry data, we investigated the detachment of membrane glycoproteins from the platelet cytoskeleton in activated platelet subpopulations, and the formation of PS-positive, balloon-like structures using confocal microscopy. Resting platelets adhered to immobilized fibrinogen were activated with thrombin and CRP, stained with fluorescently labelled CD61 (or CD42b) and annexin V, fixed with paraformaldehyde and treated with detergent. We observed the detachment of CD61-stained integrin α IIb β 3 from the cytoskeleton after the detergent treatment of fixed platelets only in activated PS-positive platelets ( Figure 6 ). All PS-positive platelets detected by annexin V binding were balloon-like cells ( Figure 6 and see Supplementary Figure S3A ). The detachment of membrane glycoproteins from the platelet cytoskeleton was observed over the entire surface of balloon-like platelets, excluding their 'cap'-like domain on the platelet surface ( Figure 6 ). Similar results were obtained for activated platelets stained with fluorophore-conjugated antibody to GpIb (see Supplementary Figure S3A ).
Shear-induced detachment and adherence of PS-positive platelets
Following the suggestion that the detachment of key glycoproteins from the surface should affect the adhesive properties of platelets, we investigated the ability of PS-positive platelets to resist shear-induced detachment from the immobilized fibrinogen in the absence or presence of the calpain inhibitor MDL28170 (Figures 7A-7C ). Platelets were allowed to attach to fibrinogen, preincubated with calpain inhibitor or vehicle control, activated with 10 μM A23187 and subjected to flow with gradually increasing shear rate. A23187 induces the formation of almost 100 % activated PS-positive platelets (data for flow cytometry not shown) and all cytoskeletal phenomena are also characteristic for those produced by A23187 (see Supplementary Figures S2A,  S3B and S3C ). All activated platelets were PS positive, as detected by annexin V binding. The ability of PS-positive platelets preincubated with the calpain inhibitor MDL28170 to resist shearinduced detachment from the immobilized fibrinogen increased about 10-fold compared with control platelets ( Figure 7C ). This result supports the hypothesis that calpain-controlled detachment of the adhesive membrane glycoproteins in activated PSpositive platelets is involved in the regulation of their adhesive properties.
To investigate whether calpain-controlled detachment of GpIb can regulate adhesion of activated PS-positive platelets, we analysed the adherence of resting platelets (as a positive control), activated PS-positive platelets and PS-positive platelets preincubated with calpain inhibitor to human vWf. Platelets were activated with 10 μM A23187 (inducing the formation of almost 100 % activated PS-positive platelets, data not shown). Stained resting or activated platelets were perfused through the flow chamber, and then non-adherent platelets were washed away and adherent platelets visualized using confocal microscopy ( Figure 7D ). The ability of PS-positive platelets to adhere to immobilized vWf was low and not affected by preincubation with the calpain inhibitor MDL28170 ( Figure 7D ). This result indicates that inhibition of calpain-controlled detachment of the GpIb in activated PS-positive platelets is not sufficient for the restoration of their ability to adhere to immobilized vWf.
DISCUSSION
The present study aimed to investigate the attachment of membrane glycoproteins to the membrane cytoskeleton in two main platelet subpopulations produced on strong physiological activation. The main finding is that detachment of key membrane glycoproteins (integrin α IIb β 3 , GpIb and P-selectin) from the membrane skeleton of platelets is observed in the PS-positive subpopulation only and is mediated by a calcium-activated protease calpain. Of particular interest is our demonstration that P-selectin, similar to other adhesive molecules, is attached to the cytoskeleton in PS-negative platelets. We also show that detachment of membrane glycoproteins may be involved in the regulation of adhesive properties of activated PS-positive platelets.
The main hindrance preventing investigation of such an attachment was platelet heterogeneity: any suspension of activated platelets typically contains at least two subpopulations. In addition to this, platelet subpopulations are normally distinguished by annexin V binding to PS, and any attempt to study their cytoskeleton usually requires removal of the membrane with a detergent, which also removes all traces of PS and annexin V. To overcome this, we took advantage of the fact that PS-positive platelets are PAC-1 negative [29] at least under the conditions of the present study [35] . So, we developed a novel flow cytometry-based approach that allowed us to investigate the status of membrane protein attachment in different subpopulations of platelets, by differentiating them with PAC-1 staining. Importantly, this should be distinguished from the shedding phenomenon: shedding of membrane proteins cannot be detected using our method, because it means the naturally occurring release of membrane protein fragments from the platelet surface, which would in our case occur before cell fixation and detergent treatment.
Our results on glycoprotein detachment observed in activated PS-positive platelets are consistent with a previous observation that degradation of some cytoskeletal proteins on platelet stimulation correlates with prothrombinase activity [31] , which depends on PS levels at the cell surface, and also with TEM studies showing that the interior of the procoagulant platelet is grey and devoid of the clearly observed structures [36] . However, these data were indirect, and our finding that the linkage of membrane glycoproteins to the platelet cytoskeleton is almost completely destroyed in activated PS-positive platelets is, to our knowledge, the first such report.
P-selectin is a key adhesion molecule of stimulated platelets mediating platelet-leukocyte binding in vivo [37] , and, as such, could be expected to be connected to the platelet skeleton to ensure reliable attachment. However, it remained the only major platelet attachment receptor with an association with the membrane skeleton that has not been investigated. Our data indicate, for the first time, that P-selectin is associated with the platelet membrane skeleton in activated PS-negative platelets, but partial disruption of this linkage occurs in activated PS-positive platelets (see Figure 3A ). P-selectin is different from other adhesion receptors because it is originally contained in α-granules, and so platelet activation should trigger its connection to the cytoskeleton first and then its disconnection in the PS-positive subpopulation. Further research is needed to elucidate specific mechanisms of this attachment and detachment.
Despite differences in attachment mechanisms of integrin α IIb β 3 , GpIb and P-selectin, our data suggest that there is a universal calpain-dependent mechanism controlling their detachment in PS-positive platelets. These data are entirely consistent with previous observations that calpain activation is associated with a marked reduction in platelet-mediated fibrin clot retraction, and pretreating platelets with calpain inhibitors prevented the calpain-mediated reduction in clot retraction [38]. However, the complete deficiency of μ-calpain causes a significant reduction in platelet aggregation and clot retraction [39] , which suggests a more complex function for calpain in platelets. It should also be noted that the three cytoskeletal proteins studied (talin, filamin, and myosin) are far from a complete set of adaptor proteins involved in platelet receptor activation and undergoing numerous modifications, of which calpain is just one possibility. Additional research is needed to obtain a comprehensive picture of how these proteins are regulated in different platelet subpopulations. It has previously been shown that the relative ability of different inducers to trigger PS exposure on platelet activation correlated with the degradation of cytoskeletal proteins [40] . Our data are consistent with previous reports indicating that only PS-positive platelets contain activated calpain [41] .
In agreement with previous observations [42, 43] , we did not observe inhibition of PS exposure on platelet activation in the presence of calpain inhibitors (see Supplementary Figure S2B ). This result suggests that calpain activation is not involved in the formation of PS-positive, procoagulant platelets. Calpain is activated in various necrotic and apoptotic conditions, whereas caspase-3 activation is a unique feature of apoptosis. Recent studies have demonstrated that calpain inhibitors can protect against necrotic neuronal death and, to a lesser extent, apoptotic death [44] . Procoagulant platelets exhibit the characteristic features of dying cells. Recent studies have demonstrated that the platelet procoagulant function can occur independently of apoptosis [45] , although platelets can undergo programmed cell death, such as apoptosis, which plays an important role in clearing platelets from the circulation. Also it has recently been shown that agonist-induced PS exposure is entirely dependent on transmembrane protein TMEM16F, whereas TMEM16F is not required for caspase-dependent PS exposure [46] . All these results suggest that PS exposure on platelet activation and during platelet apoptosis is controlled by different death pathways.
In the present study, microparticle production was observed on formation of PS-positive platelets (see Figure 6 ), and this result correlates completely with previous studies showing that agonist-induced, PS-positive platelets release microparticles [47] . Calpain activation plays a central role not only in the detachment of glycoproteins from the cytoskeleton (see Figure 5 ), but also in microparticle formation [41, 48] . We suggest that both processes are directly related to the remodelling of the cytoskeleton observed in activated PS-positive platelets. Disruption of the platelet microtubule cytoskeleton was involved in the formation of balloon-like, PS-positive platelets, and membrane ballooning correlated with microparticle generation and the procoagulant function of platelets [49] .
In the present study, the disruption of the attachment of membrane glycoproteins is observed only in PS-positive platelets (see Figures 1-3 ). Our kinetic measurements of the detachment of integrin α IIb β 3 from the cytoskeleton also show that the disruption of platelet cytoskeleton continues after PS exposure (see Figure 5 ). We assume that PS exposure precedes cytoskeletal remodelling in activated platelets; however, it is probable that PS exposure and calpain-controlled destruction of membrane glycoprotein attachment to the platelet cytoskeleton are independent, calciumregulated events. This assumption is also supported by previous studies showing that PS exposure on the platelet plasma membrane during activation is independent of cytoskeletal reorganization [50] . Recent studies also suggest that integrin β cleavage by calpain and PS exposure are mediated by distinct pathways subsequent to mitochondrial membrane permeability transition pore formation [51] . Our studies did not find any role for calpain in the integrin inactivation of PS-positive platelets (see Supplementary Figure S2 ), in contrast to the work of Mattheij et al. [52] . This difference is probably caused by different methods of data analysis based on either the percentage of PS-positive platelets [52] or the mean fluorescence intensity of platelet subpopulations (see Supplementary Figure S2 ). However, the final result of the present study suggests a revision of mechanisms of procoagulant platelet adhesion/aggregation that go beyond their well-known 'integrin inactivation' phenomenon.
The experiments in the present study showed a significant difference in the ability of PS-positive platelets to resist shearinduced detachment in the absence or presence of calpain inhibitor (see Figure 7) . This finding suggests that calpain can regulate adhesive properties of activated PS-positive platelets as a result of the control of membrane glycoprotein attachment. In contrast, the ability of PS-positive platelets to adhere to immobilized vWF at a low shear rate was low and not affected by platelet preincubation with calpain inhibitor (see Figure 7) . These data are consistent with the observation that exposure of platelets that have a mutant form of human GpIb (which has a selective defect in its ability to bind filamin A) to pathological shear rates (5000-40000/s) leads to defective platelet adhesion, whereas there is no difference between wild-type and GpIb mutant platelets at low shear rates [53] . In our experiments in the present study, the adherence of PS-positive platelets to immobilized vWF was extremely low even at a low shear rate (100/s). It may be related not only to GpIb detachment from the platelet cytoskeleton but also to integrin α IIb β 3 inactivation (see Supplementary Figure S1 ) and signalling changes in PS-positive platelets. It has recently been shown that the GPIb β-intracellular domain is involved in controlling the adhesive properties of the GPIb-V-IX complex through phosphorylation of GPIb β-Ser 166 [54] . At the same time, it is known that the formation of PS-positive platelets is associated with extensive protein tyrosine dephosphorylation [55] .
Indeed, the (patho)physiological function of procoagulant platelets is not currently clear, but it has long been shown to be associated with impairment of platelet thrombus formation [51, 56] . Paradoxical inactivation of integrin α IIb β 3 in these platelets [29] has remained the only explanation for this impairment. We recently demonstrated directly that indeed these platelets cannot normally aggregate but can be involved in aggregates [19] via their unique fibrin-rich 'caps' [57] . However, the finding of the present study that calpain-mediated detachment of glycoproteins from the cytoskeleton down-regulates PSpositive platelet adhesive capabilities (see Figure 7) suggests a more general view: neither integrin α IIb β 3 nor GpIb is sufficiently attached to the cytoskeleton to hold the platelet in place. Our result reinforces and supports the concept of procoagulant platelets as 'weak links' in thrombi: they can become attached (via 'caps' or via GpIb before becoming procoagulant) but cannot hold unless they are surrounded by 'normal' (PS-negative) platelets or a fibrin network. Detachment of all adhesive proteins from a PS-positive platelet cytoskeleton and remodelling of the cytoskeleton itself make these platelets useless as 'bearing components'. It could be speculated that their role is specifically limited to a 'regulating' capacity.
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